Boster Bio Life Science Blog

Can western blot results from different gels or different experimental days be compared? This article explains why raw band intensity values should not be directly compared, and how loading controls, bridge samples, and appropriate normalization strategies can help researchers evaluate relative protein expression changes more reliably.

Learn how to plan rare-event flow cytometry experiments based on target frequency, positive-event counts, cell recovery, and background—so you can collect enough events without relying on arbitrary thresholds.

An unexpected molecular weight does not automatically mean the antibody failed. A cleaner troubleshooting sequence is to establish band identity first, then use the shift pattern to choose a mechanism-specific control.

A Western blot band appearing above or below the predicted molecular weight is easy to treat as a technical failure. Sometimes it is. But the number calculated from a protein sequence is not always the number that appears on an SDS-PAGE gel.

Glycosylation can increase or broaden apparent molecular weight. Proteolytic processing can convert a precursor into a smaller mature protein or generate stable fragments. Poor sample handling can produce lower-molecular-weight bands through degradation. And some proteins migrate anomalously even when none of those mechanisms is involved.

The useful question is therefore not simply, “Why is this band at the wrong size?” It is, “What control would distinguish one explanation from another?” Boster’s Western Blotting Troubleshooting Guide lists wrong band size among common WB problems; this article focuses on the next step: choosing controls...

Will your cells be fixed before acquisition? This guide explains when to use fixable or nonfixable viability dyes and how to avoid common workflow mistakes.

A merged IF image can look convincing—but apparent overlap in a maximum-intensity projection may come from different Z-planes. Learn how to check whether colocalization is truly spatial.

A high R² doesn’t always mean your ELISA standard curve is reliable. Learn how residuals, back-calculated standards, weighting, and 4PL vs 5PL models can reveal curve-fit errors and improve quantitative accuracy.

High background in flow cytometry is not always an antibody-specificity problem. Cells that express Fc receptors can capture antibodies through the Fc region, adding fluorescence that is unrelated to the target antigen. The result may be a higher negative population, poorer separation, or an apparently positive population that is difficult to interpret.

Fc blocking in flow cytometry is used to reduce that Fc receptor-mediated component before antibody staining. The more useful questions are when the step is likely to matter, how inadequate blocking appears in the data, and whether the blocker can interfere with a marker in the panel.

Those answers depend on the sample. Fc receptor expression varies with lineage and activation state, and blocker chemistry and antibody isotype also matter. For an unfamiliar preparation, a blocked-versus-unblocked comparison is often the quickest way to see whether Fc-mediated binding is affecting the assay.

In This Article

1. What Is Fc Blocking in Flow Cytometry?
2. Why Fc Blocking Matters
3. When Do You Need Fc Blocking?
4. Common Fc Receptors and Relevant Cell Types
5. What Does Insufficient Fc Blocking Look Like?
6. Can Fc Blocking Interfere With Staining?
7. How to Use Fc Blocking Reagent
8. How to Optimize Fc Blocking
9. Fc Blocking Does Not Fix Every Background Problem
10. Quick Troubleshooting: Is the Background Fc-Mediated?
11. Takeaway
12. References
13. Frequently Asked Questions

1. What Is Fc Blocking in Flow Cytometry?

Most flow cytometry antibodies contain an antigen-binding Fab region and an Fc region. The Fab region recognizes the target antigen; the Fc region can also interact with Fc receptors on leukocytes. When that second interaction contributes to staining, the measured fluorescence is no longer explained by antigen binding alone. [1,5,6]

Fc blocking reduces this unwanted binding by occupying or inhibiting Fc receptors before the staining antibodies are added. Depending on the system, the blocker may be a receptor-specific antibody, purified immunoglobulin, serum-derived immunoglobulin, or a commercial Fc receptor-blocking formulation. [1,5,6]

2. Why Fc Blocking Matters

Fc-mediated binding can raise background, shift negative populations, and make dim or rare populations harder to resolve. In complex samples, it can compound other artifacts such as dead cells and doublets, particularly when profiling tumor-infiltrating immune cells. Fc blocking addresses the Fc-mediated component; viability and singlet controls still need to be handled separately. [1,2]

3. When Do You Need Fc Blocking?

The need for Fc blocking follows the cells in the tube more than the name of the assay. Vendor protocols flag monocytes, macrophages, neutrophils, B cells, NK cells, and some T-cell subsets because they can express Fc gamma receptors. But the amount of nonspecific binding is not the same across all of these populations or across antibody isotypes. [1,5,6]

Which Cells Are Most Likely to Need Fc Blocking?

Fc receptor-rich myeloid cells deserve the most attention. Lymphocyte-only assays are more variable and should be judged in the context of the panel and sample.

• Monocytes and macrophages: usually high priority. In the Andersen study, human monocytes and monocyte-derived macrophages showed strong nonspecific binding under the tested conditions. [1]
• Neutrophils and other granulocytes: often high priority. Thermo Fisher includes neutrophils among the cell types for which Fc-mediated interactions should be blocked in surface-staining workflows. [5]
• Dendritic and other myeloid populations: blocking is often useful, especially in mixed or tissue-derived samples where modest background shifts can affect a small gate. [7]
• B cells and NK cells: consider the panel and sample. Both can express Fc receptors and appear in vendor blocking guidance. In the Andersen PBMC experiments, however, the tested mouse IgG isotype controls did not show the same degree of nonspecific binding on B or NK cells as on monocytes and macrophages. [1,5,6]
• T cells: often lower priority in conventional resting T-cell assays. That does not make every T-cell preparation FcR-negative; activation state and subset can matter, so unfamiliar systems are worth checking experimentally. [5]

Which Samples Are Most Likely to Need Fc Blocking?

Sample type is a useful shortcut, but cell composition is what matters. A tumor digest rich in macrophages, for example, is a different Fc-blocking problem from a purified T-cell preparation.

Sample	Fc Blocking Consideration	Why
Whole blood	Strongly consider	Contains multiple Fc receptor-expressing leukocyte populations, including monocytes and granulocytes.
PBMCs	Often useful	Monocytes are retained, but granulocytes are largely absent after standard density separation; importance depends on the populations being analyzed.
Bone marrow	Often useful in mixed/myeloid-rich samples	Contains diverse developing and mature immune populations, including myeloid cells.
Spleen	Depends on populations analyzed	Mixed immune-cell composition can include substantial Fc receptor-positive populations.
Dissociated tumor	Strongly consider when myeloid-rich	Tumor-infiltrating myeloid cells can be particularly sensitive to Fc-mediated artifacts. [2]
Inflamed tissue	Often useful when FcR-rich	Inflammatory infiltrates can increase the proportion and activation state of Fc receptor-expressing leukocytes.
Purified monocytes/macrophages	Strongly consider	Directly enriched for populations in which Fc-mediated binding can be prominent. [1]
Purified conventional T cells	Usually lower priority	Fc-mediated background is commonly less prominent, but activation state and panel composition still matter.
Fc receptor-negative cultured cells	Usually low priority if truly FcR-negative	A blocker may add little if the cells do not express relevant Fc receptors and no other Fc-interacting component is present.

4. Common Fc Receptors and Relevant Cell Types

For IgG-based staining, CD64 (Fc gamma RI), CD32 (Fc gamma RII), and CD16 (Fc gamma RIII) are the receptors most often encountered in this context. Their expression varies by lineage, differentiation state, and activation. BD and Thermo Fisher guidance discusses CD16/CD32-associated Fc-mediated binding across B cells, NK cells, granulocytes, monocytes, and macrophages. [5,6]

...

Fc receptor	Commonly relevant populations	Note
CD64 / Fc gamma RI	Especially important in myeloid populations such as monocytes/macrophages	High-affinity Fc gamma receptor; blocker compatibility depends on reagent design.
CD32 / Fc gamma RII	B cells, monocytes, macrophages, granulocytes and other FcR-positive cells	A major target of common mouse anti-CD16/CD32 blocking antibodies. [6]
CD16 / Fc gamma RIII	NK cells, neutrophils, macrophage/monocyte subsets